Mens Health Policy

You are here: Home » Advocacy » Prostate Cancer (LCA) Petition
Friday, 20 Oct 2017

A Petition to Congress to Ensure Access to Vital Prostate Cancer Drug Therapies

E-mail Print PDF
  • Because prostate cancer is the most common cancer in men and the second leading killer of men.
  • Because a full range of approved drug therapies are currently available to treat prostate cancer.
  • Because Medicare's 'least costly alternative' (LCA) policy allows the government to interfere with prostate cancer patients' access to those approved therapies solely due to cost.
  • Because the LCA policy unfairly singles out prostate cancer patients, disproportionately affects low-income patients, and does not apply to other conditions.
  • Because the government should not interfere with treatment decisions made between prostate cancer patients and their physicians.
  • Because the U.S. Court of Appeals has ruled that CMS does not have the statutory authority to continue the least costly alternative policy.

We, the undersigned, petition Congress to demand that Medicare rescind the LCA policy for prostate cancer drug therapies to ensure patients have equitable access to vital drug treatments.


First Name *
Last Name *
Address Line 1
Address Line 2
State *
Zip *
Email *
Add me to Policy email list

* = required field